6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone Additional name: 6-[4-(1-Cyclohexyl-5-tetrazolyl)butoxy]-1,2,3,4- tetrahydro-2-oxoquinolinone(73963-72-1)
Product Identification
Product Name
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone Additional name: 6-[4-(1-Cyclohexyl-5-tetrazolyl)butoxy]-1,2,3,4- tetrahydro-2-oxoquinolinone
Synonyms
3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone
Cilostazol
OPC-13013
OPC-21
Pletaal
CAS
73963-72-1
Formula
C20H27N5O2
Molecular Weight
369.47
RTECS
VC8277500
Merck
12,2335
Beilstein/Gmelin
3632107
Physical and Chemical Properties
Solubility in water
Insoluble
Melting Point
160
Boiling Point
665
Vapor Pressure
1.6E-17 (25 C)
Density
1.34 g/cm3 (20 C)
pKa/pKb
11.81 (pKb)
Partition Coefficient
3.05
Heat Of Vaporization
97.7 kJ/mol
Usage
Used in the alleviation of the symptom of intermittent claudication in individuals with peripheral vascular disease.
Hazards Identification
Inhalation
Remove to fresh air. If not breathing give artificial respiration. If breathing is difficult, give oxygen. Seek medical attention.
Skin
Immediately wash skin with soap and copious amounts of water for at least 15 minutes. If irritation persists, seek medical attention.
Eyes
Immediately flush eyes with copious amounts of water for at least 15 minutes. Seek medical advice.
Ingestion
If swallowed, wash out mouth with water, provided person is conscious. Seek medical advice.
ContactMore
- Tel
- 0755-26968666
- Fax
- 0755-2680892
- WebSite
- http://www.neptunus.com
- WebSite
- https://www.chemicalbook.com/ShowSupplierProductsList1140412/0.htm
- Tel
- 010-82848833
- Fax
- 86-10-82849933
- WebSite
- http://www.jkchemical.com
- Tel
- 021-61259108
- Fax
- 86-21-61259102
- WebSite
- https://www.meryer.com/cn/index/
- Tel
- 821-50328103-801
- Fax
- 86-21-50328109
- WebSite
- https://www.chemicalbook.com/ShowSupplierProductsList13285/0.htm